Desonide NDC 16714-729

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-729Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0729Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-729-01	16714072901	1 TUBE in 1 CARTON (16714-729-01) / 15 g in 1 TUBEMarketed from Jun 1, 2017
16714-729-02	16714072902	1 TUBE in 1 CARTON (16714-729-02) / 60 g in 1 TUBEMarketed from Jun 1, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desonide
Generic name (nonproprietary): desonide
Active ingredients: Desonide — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: NORTHSTAR RX LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 073548
Marketing start: Jun 30, 1992
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 16714-729_2ba564bf-266b-44d7-9d5f-40e20336b318SPL ID 2ba564bf-266b-44d7-9d5f-40e20336b318SPL set ID 0665dd04-1d0b-45bf-90e4-c6e0bd90956dRxCUI 349351UNII J280872D1O
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714072901 followed by a unit qualifier and the quantity

Package 16714-0729-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 19, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Desonide cream, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. It should not be used for longer than two weeks unless directed by a physician.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 073548

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073548
Product	Strength	Form · route	Labeler	Product NDC
Desonide	Desonide .5 mg/g	CreamTopical	Sun Pharmaceutical Industries, Inc.	51672-1280